摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-trifluoromethylquinoline-4-carboxylic acid | 31009-01-5

中文名称
——
中文别名
——
英文名称
8-trifluoromethylquinoline-4-carboxylic acid
英文别名
8-trifluoromethyl-quinoline-4-carboxylic acid;8-trifluoromethyl-4-quinolinecarboxylic acid;8-Trifluormethyl-chinolin-4-carbonsaeure;8-(Trifluoromethyl)quinoline-4-carboxylic acid
8-trifluoromethylquinoline-4-carboxylic acid化学式
CAS
31009-01-5
化学式
C11H6F3NO2
mdl
——
分子量
241.169
InChiKey
QCLHYUOVNZKMJW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    50.2
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and aldose reductase inhibitory activity of N-(quinolinyl thiocarbonyl) glycine derivatives
    摘要:
    The onset of diabetic complications may be prevented by the inhibition of aldose reductase. Derivatives of N-(quinolinyl thiocarbonyl) glycine were prepared and their in vitro and ex vivo aldose reductase inhibitory activities were tested on rat lens. The cincophen derivatives were the most potent in vitro with an enzyme inhibition value of 29% at 10(-8) M and 91% at 10(-7) M for the N-[(2-phenylquinolin-4-yl)thiocarbonyl]-N-methylglycine compound 10a This activity was shown to be dependent on the nature of the substituents and seems to be optimal for the acids; esters were found to be inactive. No compound have shown ex vivo inhibitory activity. It is concluded that the lack of ex vivo activity is likely due to a poor bioavailability or a bad penetration of the compounds in target tissue (lens).
    DOI:
    10.1016/0223-5234(92)90032-v
  • 作为产物:
    描述:
    8-trifluoromethylquinoline-2,4-dicarboxylic acid二苯醚 为溶剂, 反应 0.25h, 以87%的产率得到8-trifluoromethylquinoline-4-carboxylic acid
    参考文献:
    名称:
    Synthesis and aldose reductase inhibitory activity of N-(quinolinyl thiocarbonyl) glycine derivatives
    摘要:
    The onset of diabetic complications may be prevented by the inhibition of aldose reductase. Derivatives of N-(quinolinyl thiocarbonyl) glycine were prepared and their in vitro and ex vivo aldose reductase inhibitory activities were tested on rat lens. The cincophen derivatives were the most potent in vitro with an enzyme inhibition value of 29% at 10(-8) M and 91% at 10(-7) M for the N-[(2-phenylquinolin-4-yl)thiocarbonyl]-N-methylglycine compound 10a This activity was shown to be dependent on the nature of the substituents and seems to be optimal for the acids; esters were found to be inactive. No compound have shown ex vivo inhibitory activity. It is concluded that the lack of ex vivo activity is likely due to a poor bioavailability or a bad penetration of the compounds in target tissue (lens).
    DOI:
    10.1016/0223-5234(92)90032-v
点击查看最新优质反应信息

文献信息

  • [EN] QUINOLYL AMIDE DERIVATIVES AS CCR-5 ANTAGONISTS<br/>[FR] DERIVES DE QUINOLYLE AMIDE ANTAGONISTES DE CCR-5
    申请人:SCHERING AG
    公开号:WO2004113323A1
    公开(公告)日:2004-12-29
    The present invention relates to a series of compounds which are CCR-5 receptor antagonists of the general formula (I): or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein.
    本发明涉及一系列化合物,其为一般式(I)的CCR-5受体拮抗剂,或其药学上可接受的盐,其中变量在此处定义。
  • Quinolyl amide derivatives as CCR-5 antagonists
    申请人:Lu Shou-Fu
    公开号:US20050020605A1
    公开(公告)日:2005-01-27
    The present invention relates to a series of compounds which are CCR-5 receptor antagonists of the general formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein.
    本发明涉及一系列通式I的CCR-5受体拮抗剂化合物,或其药学上可接受的盐,其中变量在此定义。
  • Kgokong, Joseph L.; Breytenbach, Jaco C., South African Journal of Chemistry, 2000, vol. 53, # 2, p. 100 - 103
    作者:Kgokong, Joseph L.、Breytenbach, Jaco C.
    DOI:——
    日期:——
  • QUINOLYL AMIDE DERIVATIVES AS CCR-5 ANTAGONISTS
    申请人:Schering Aktiengesellschaft
    公开号:EP1633737A1
    公开(公告)日:2006-03-15
  • US4970214A
    申请人:——
    公开号:US4970214A
    公开(公告)日:1990-11-13
查看更多